Skip to main content
SpringerLink
Log in
Book cover

Advances in Mitochondrial Medicine pp 347–369Cite as

Iatrogenic Mitochondriopathies: A Recent Lesson from Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 942))

Abstract

The use of nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) has revolutionized the treatment of infection by human immunodeficiency virus (HIV) and hepatitis-B virus. NRTIs can suppress viral replication in the long-term, but possess significant toxicity that can seriously compromise treatment effectiveness. The major toxicity of NRTIs is mitochondrial toxicity. This manifests as serious side effects such as myopathy, peripheral neuropathy and lactic acidosis. In general, it is believed that the mitochondrial pathogenesis is closely related to the effect of NRTIs on mitochondrial DNA polymerase-γ. Depletion and mutation of mitochondrial DNA during chronic NRTI therapy may lead to cellular respiratory dysfunction and release of reactive oxidative species, resulting in cellular damage. It is now apparent that the etiology is far more complex than originally thought. It appears to involve multiple mechanisms as well as host factors such as HIV per se, inborn mitochondrial mutation, and sex. Management of mitochondrial toxicity during NRTI therapy remains a challenge. Interruption of NRTI therapy and substitution of the causative agents with alternative better-tolerated NRTIs represents the mainstay of management for mitochondrial toxicity and its clinical manifestations. A range of pharmacological approaches has been proposed as treatments and prophylaxes.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Adani GL, Baccarani U, Risaliti A, Bresadola F, Della Rocca G, Viale P (2005) Rhabdomyolysis due to Lamivudine administration in a liver transplant recipient. Am J Transplant 5(3):634

    Article  PubMed  Google Scholar 

  • Affandi JS, Price P, Imran D, Yunihastuti E, Djauzi S, Cherry CL (2008) Can we predict neuropathy risk before stavudine prescription in a resource-limited setting? AIDS Res Hum Retroviruses 24(10):1281–1284

    Article  PubMed  CAS  Google Scholar 

  • Allaouchiche B, Duflo F, Cotte L, Mathon L, Chassard D (1999) Acute pancreatitis with severe lactic acidosis in an HIV infected patient on didanosine therapy. J Antimicrob Chemother 44(1):137–138

    Article  PubMed  CAS  Google Scholar 

  • Al-Madhoun AS, Tjarks W, Eriksson S (2004) The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Mini Rev Med Chem 4(4):341–350

    PubMed  CAS  Google Scholar 

  • Amacher DE (2005) Drug-associated mitochondrial toxicity and its detection. Curr Med Chem 12(16):1829–1839

    Article  PubMed  CAS  Google Scholar 

  • Amarapurkar DN (2007) Telbivudine: a new treatment for chronic hepatitis B. World J Gastroenterol 13(46):6150–6155

    Article  PubMed  CAS  Google Scholar 

  • Anderson PL, Kakuda TN, Kawle S, Fletcher CV (2003) Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals. AIDS 17(15):2159–2168

    Article  PubMed  CAS  Google Scholar 

  • Anderson PL, Kakuda TN, Lichtenstein KA (2004) The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities. Clin Infect Dis 38(5):743–753

    Article  PubMed  CAS  Google Scholar 

  • Arnér ES, Spasokoukotskaja T, Eriksson S (1992) Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem Biophys Res Commun 188(2):712–718

    Article  PubMed  Google Scholar 

  • Bailey CM, Kasiviswanathan R, Copeland WC, Anderson KS (2009) R964C mutation of DNA polymerase gamma imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity. Antimicrob Agents Chemother 53(6):2610–2612

    Article  PubMed  CAS  Google Scholar 

  • Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, Young JD (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280(16):15880–15887

    Article  PubMed  CAS  Google Scholar 

  • Balzarini J (1994) Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives. Pharm World Sci 16(2):113–126

    Article  PubMed  CAS  Google Scholar 

  • Balzarini J, Herdewijn P, De Clercq E (1989) Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine (d4T) and 3′-azido-2′,3′-dideoxythymidine (AZT), two potent anti-HIV compounds. J Biol Chem 264(11):6127–6133

    PubMed  CAS  Google Scholar 

  • Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C, ANRS Hc02-Ribavic Study Team (2005) Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. J Acquir Immune Defic Syndr 40(1):47–52

    Article  PubMed  CAS  Google Scholar 

  • Barile M, Valenti D, Hobbs GA, Abruzzese MF, Keilbaugh SA, Passarella S, Quagliariello E, Simpson MV (1994) Mechanisms of toxicity of 3′-azido-3′-deoxythymidine. Its interaction with adenylate kinase. Biochem Pharmacol 48(7):1405–1412

    Article  PubMed  CAS  Google Scholar 

  • Barile M, Valenti D, Passarella S, Quagliariello E (1997) 3′-Azido-3′-deoxythmidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator. Biochem Pharmacol 53(7):913–920

    Article  PubMed  CAS  Google Scholar 

  • Barry M, Wild M, Veal G, Back D, Breckenridge A, Fox R, Beeching N, Nye F, Carey P, Timmins D (1994) Zidovudine phosphorylation in HIV infected patients and seronegative volunteers. AIDS 8(8):F1–F5

    Article  PubMed  CAS  Google Scholar 

  • Behbahani H, Landay A, Patterson BK, Jones P, Pottage J, Agnoli M, Andersson J, Spetz AL (2000) Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy. J Acquir Immune Defic Syndr 25(2):150–156

    Article  PubMed  CAS  Google Scholar 

  • Benbrik E, Chariot P, Bonavaud S, Ammi-Saïd M, Frisdal E, Rey C, Gherardi R, Barlovatz-Meimon G (1997) Cellular and mitochondrial toxicity of ziduvodine (AZT), didanosine(ddl) and zalcitabine(ddC) on cultured human cells. J Neurol Sci 149(1):19–25

    Article  PubMed  CAS  Google Scholar 

  • Birkus G, Hajek M, Kramata P, Votruba I, Holy A, Otova B (2002) Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon. Antimicrob Agents Chemother 46(3):1610–1613

    Article  PubMed  CAS  Google Scholar 

  • Birkus G, Gibbs CS, Cihlar T (2003) Comparative effects of adefovir and selected nucleoside inhibitors of hepatitis B virus DNA polymerase on mitochondrial DNA in liver and skeletal muscle cells. J Viral Hepat 10(1):50–54

    Article  PubMed  CAS  Google Scholar 

  • Bissuel F, Bruneel F, Habersetzer F, Chassard D, Cotte L, Chevallier M, Bernuau J, Lucet JC, Trepo C (1994) Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med 235(4):367–372

    Article  PubMed  CAS  Google Scholar 

  • Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, Ciraru-Vigneron N, Lacroix C, Rouzioux C, Mandelbrot L, Desguerre I, Rötig A, Mayaux MJ, Delfraissy JF (1999) Persistant mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 354(9184):1084–1089

    Article  PubMed  CAS  Google Scholar 

  • Bolhaar MG, Karstaedt AS (2007) A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Clin Infect Dis 45(2):254–260

    Article  PubMed  CAS  Google Scholar 

  • Bourdais J, Biondi R, Sarfati S, Guerreiro C, Lascu I, Janin J, Véron M (1996) Cellular phosphorylation of anti-HIV nucleosides. J Biol Chem 271(14):7887–7890

    Article  PubMed  CAS  Google Scholar 

  • Bremer J (1990) The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 28(5):297–301

    PubMed  CAS  Google Scholar 

  • Bridges EG, Jiang Z, Cheng YC (1999) Characterization of a dCTP transport activity reconstituted from human mitochondria. J Biol Chem 274(8):4620–4625

    Article  PubMed  CAS  Google Scholar 

  • Brinkman K, ter Hofstede HJ (1999) Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: lactic acidosis, risk factors and therapeutic options. AIDS Rev 1:141–148

    Google Scholar 

  • Butt AA (2003) Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy. AIDS Read 13(7):344–348

    PubMed  Google Scholar 

  • Carr A, Workman C, Smith DE, Hoy J, Hudson J, Doong N, Martin A, Amin J, Freund J, Law M, Cooper DA, Mitochondrial Toxicity (MITOX) Study Group (2002) Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA 288(2):207–215

    Article  PubMed  CAS  Google Scholar 

  • Casademont J, Barrientos A, Grau JM, Pedrol E, Estivill X, Urbano-Marquez A, Nunes V (1996) The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction. Brain 119(Pt 4):1357–1364

    Article  PubMed  Google Scholar 

  • Cepeda A, Wilks D (2000) Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection. AIDS 14(3):332–333

    Article  PubMed  CAS  Google Scholar 

  • Chariot P, Drogou I, de Lacroix-Szmania I, Eliezer-Vanerot MC, Chazaud B, Lombes A, Schaeffer A, Zafrani ES (1999) Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol 30(1):156–160

    Article  PubMed  CAS  Google Scholar 

  • Chen R, Nelson JA (2000) Role of organic cation transporters in the renal secretion of nucleosides. Biochem Pharmacol 60(2):215–219

    Article  PubMed  CAS  Google Scholar 

  • Cherry CL, Gahan ME, McArthur JC, Lewin SR, Hoy JF, Wesselingh SL (2002) Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J Acquir Immune Defic Syndr 30(3):271–277

    PubMed  CAS  Google Scholar 

  • Cherry CL, McArthur JC, Hoy JF, Wesselingh SL (2003) Nucleoside analogues and neuropathy in the era of HAART. J Clin Virol 26(2):195–207

    Article  PubMed  CAS  Google Scholar 

  • Cherry CL, Nolan D, James IR, McKinnon EJ, Mallal SA, Gahan ME, Lal L, McArthur JC, Wesselingh SL (2006) Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals. JAcquir Immune Defic Syndr 42(4):435–440

    Article  CAS  Google Scholar 

  • Cihlar T, Ray AS, Boojamra CG, Zhang L, Hui H, Laflamme G, Vela JE, Grant D, Chen J, Myrick F, White KL, Gao Y, Lin KY, Douglas JL, Parkin NT, Carey A, Pakdaman R, Mackman RL (2008) Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. Antimicrob Agents Chemother 52(2):655–665

    Article  PubMed  CAS  Google Scholar 

  • Collier AC, Helliwell RJ, Keelan JA, Paxton JW, Mitchell MD, Tingle MD (2003) 30-Azido-30-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta. Toxicol Appl Pharmacol 192(2):164–173

    Article  PubMed  CAS  Google Scholar 

  • Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O’Shaughnessy MV, Montaner JS (2002) Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 346(11):811–820

    Article  PubMed  Google Scholar 

  • Currier JS (2007) Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women. Clin Infect Dis 45(11):261–262

    Article  PubMed  CAS  Google Scholar 

  • Dabis F, Ekpini ER (2002) HIV-1/AIDS and maternal and child health in Africa. Lancet 359(9323):2097–2104

    Article  PubMed  Google Scholar 

  • Dagan T, Sable C, Bray J, Gerschenson M (2002) Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence. Mitochondrion 1(5):397–412

    Article  PubMed  CAS  Google Scholar 

  • Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322(16):1098–1105

    Article  PubMed  CAS  Google Scholar 

  • Dambrova M, Liepinsh E, Kalvinsh I (2002) Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc Med 12(6):275–279

    Article  PubMed  CAS  Google Scholar 

  • De Clercq E (2004) Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster. Biochem Pharmacol 68(12):2301–2315

    Article  PubMed  CAS  Google Scholar 

  • de la Asuncion JG, del Olmo ML, Sastre J, Millan A, Pellin A, Pallardo FV, Vina J (1998) AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J Clin Invest 102(1):4–9

    Article  PubMed  Google Scholar 

  • Dolce V, Fiermonte G, Runswick MJ, Palmieri F, Walker JE (2001) The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals. Proc Natl Acad Sci USA 98(5):2284–2288

    Article  PubMed  CAS  Google Scholar 

  • Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Liou SH, Brown MJ, Cross AP, Hirsch MS, Hardy WD, Mildvan D, Blair DC, Powderly WG, Para MF, Fife KH, Steigbigel RT, Smaldone L, AIDS Clinical Trials Group (1995) Zidovudine compared with didanosine in patients with advanced HIV-1 infection and little or no previous experience with zidovudine. Arch Intern Med 155(9):961–974

    Article  PubMed  CAS  Google Scholar 

  • Domanski MJ, Sloas MM, Follmann DA, Scalise PP 3rd, Tucker EE, Egan D, Pizzo PA (1995) Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr 127(1):137–146

    Article  PubMed  CAS  Google Scholar 

  • Duong Van Huyen JP, Batisse D, Heudes D, Belair MF, Piketty C, Gonzalez-Canali G, Weiss L, Kazatchkine MD, Bruneval P (2006) Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients. Mod Pathol 19(10):1277–1288

    Article  PubMed  CAS  Google Scholar 

  • Elimadi A, Morin D, Albengres E, Chauvet-Monges AM, Allain V, Crevat A, Tillement JP (1997) Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation. Br J Pharmacol 121(7):1295–1300

    Article  PubMed  CAS  Google Scholar 

  • Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC (1999) Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 96(9):4820–4825

    Article  PubMed  CAS  Google Scholar 

  • Faletto MB, Miller WH, Garvey EP, St Clair MH, Daluge SM, Good SS (1997) Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89. Antimicrob Agents Chemother 41(5):1099–1107

    PubMed  CAS  Google Scholar 

  • Falkenberg M, Larsson NG, Gustafsson CM (2007) DNA replication and transcription in mammalian mitochondria. Annu Rev Biochem 76:679–699

    Article  PubMed  CAS  Google Scholar 

  • Famularo G, Moretti S, Marcellini S, Trinchieri V, Tzantzoglou S, Santini G, Longo A, De Simone C (1997) Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 11(2):185–190

    Article  PubMed  CAS  Google Scholar 

  • Fichtenbaum CJ, Clifford DB, Powderly WG (1995) Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 10(2):169–174

    Article  PubMed  CAS  Google Scholar 

  • Fleischer RD, Lok AS (2009) Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B. J Hepatol 51(4):787–791

    Article  PubMed  CAS  Google Scholar 

  • Fodale V, Mazzeo A, Praticò C, Aguennouz M, Toscano A, Santamaria LB, Vita G (2005) Fatal exacerbation of peripheral neuropathy during lamivudine therapy: evidence for iatrogenic mitochondrial damage. Anaesthesia 60(8):806–810

    Article  PubMed  CAS  Google Scholar 

  • Foli A, Benvenuto F, Piccinini G, Bareggi A, Cossarizza A, Lisziewicz J, Lori F (2001) Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS 15(13):1687–1694

    Article  PubMed  CAS  Google Scholar 

  • Fouty B, Frerman F, Reves R (1998) Riboflavin to treat nucleoside analogue-induced lactic acidosis. Lancet 352(9124):291–292

    Article  PubMed  CAS  Google Scholar 

  • Frank I, Bosch RJ, Fiscus S, Valentine F, Flexner C, Segal Y, Ruan P, Gulick R, Wood K, Estep S, Fox L, Nevin T, Stevens M, Eron JJ Jr, ACTG 307 Protocol Team, (2004) Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. AIDS Res Hum Retroviruses 20(9):916–926

    Article  PubMed  CAS  Google Scholar 

  • Frick LW, Nelson DJ, St Clair MH, Furman PA, Krenitsky TA (1988) Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem Biophys Res Commun 154(1):124–129

    Article  PubMed  CAS  Google Scholar 

  • Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H, Barry DW (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83(21):8333–8337

    Article  PubMed  CAS  Google Scholar 

  • Gao WY, Shirasaka T, Johns DG, Broder S, Mitsuya H (1993) Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest 91(5):2326–2333

    Article  PubMed  CAS  Google Scholar 

  • Gao WY, Agbaria R, Driscoll JS (1994) Mitsuya H. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2,3-dideoxynucleoside analogs in resting and activated human cells. J Biol Chem 269(17):12633–12638

    PubMed  CAS  Google Scholar 

  • Gattermann N, Dadak M, Hofhaus G, Wulfert M, Berneburg M, Loeffler ML, Simmonds HA (2004) Severe impairment of nucleotide synthesisthrough inhibition of mitochondrial respiration. Nucleosides Nucleotides Nucleic Acids 23(8–9):1275–1279

    Article  PubMed  CAS  Google Scholar 

  • Gerschenson M, Poirier MC (2000) Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure. Ann N Y Acad Sci 918:269–281

    Article  PubMed  CAS  Google Scholar 

  • Gertner E, Thurn JR, Williams DN, Simpson M, Balfour HH Jr, Rhame F, Henry K (1989) Zidovudine-associated myopathy. Am J Med 86(6 Pt 2):814–818

    Article  PubMed  CAS  Google Scholar 

  • Godfried MH, van der Poll T, Jansen J, Romijin JA, Schattenkerk JK, Endert E, van Deventer SJ, Sauerwein HP (1993) Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7(1):33–36

    Article  PubMed  CAS  Google Scholar 

  • Govindarajan R, Leung GP, Zhou M, Tse CM, Wang J, Unadkat JD (2009) Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am J Physiol Gastrointest Liver Physiol 296(4):G910–G922

    Article  PubMed  CAS  Google Scholar 

  • Gray NM, Marr CL, Penn CR, Cameron JM, Bethell RC (1995) The intracellular phosphorylation of (-)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase gamma. Biochem Pharmacol 50(7):1043–1051

    Article  PubMed  CAS  Google Scholar 

  • Graziewicz MA, Longley MJ, Copeland WC (2006) DNA polymerase gamma in mitochondrial DNA replication and repair. Chem Rev 106(2):383–405

    Article  PubMed  CAS  Google Scholar 

  • Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP, Oh DM, Sadée W, Amidon GL (1998) Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res 15(8):1154–1159

    Article  PubMed  CAS  Google Scholar 

  • Hanes JW, Johnson KA (2008) Exonuclease removal of dideoxycytidine (zalcitabine) by the human mitochondrial DNA polymerase. Antimicrob Agents Chemother 52(1):253–258

    Article  PubMed  CAS  Google Scholar 

  • Hart AM, Wilson AD, Montovani C, Smith C, Johnson M, Terenghi G, Youle M (2004) Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 18(11):1549–1560

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto KI, Tsunoda R, Okamoto M, Shigeta S, Baba M (1997) Stavudine selectively induces apoptosis in HIV type l-infected cells. AIDS Res Hum Retroviruses 13(2):193–199

    Article  PubMed  CAS  Google Scholar 

  • Hendrickson SL, Kingsley LA, Ruiz-Pesini E, Poole JC, Jacobson LP, Palella FJ, Bream JH, Wallace DC, O’Brien SJ (2009) Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 51(2):111–116

    Article  PubMed  CAS  Google Scholar 

  • Hervey PS, Perry CM (2000) Abacavir: a review of its clinical potential in patients with HIV infection. Drugs 60(2):447–479

    Article  PubMed  CAS  Google Scholar 

  • Hestdal K, Aukrust P, Müller F, Lien E, Bjerkeli V, Espevik T, Frøland SS (1997) Dysregulation of membrane-bound tumor necrosis factor-α and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load. Blood 90(7):2670–2679

    PubMed  CAS  Google Scholar 

  • Hill A, Ruxrungtham K, Hanvanich M, Katlama C, Wolf E, Soriano V, Milinkovic A, Gatell J, Ribera E (2007) Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment. Expert Opin Pharmacother 8(5):679–688

    Article  PubMed  CAS  Google Scholar 

  • Hoggard PG, Kewn S, Maherbe A, Wood R, Almond LM, Sales SD, Gould J, Lou Y, De Vries C, Back DJ, Khoo SH, CHARM Study Group (2002) Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea. AIDS 16(18):2439–2446

    Article  PubMed  CAS  Google Scholar 

  • Hsu CH, Hu R, Dutschman GE, Yang G, Krishnan P, Tanaka H, Baba M, Cheng YC (2007) Comparison of the phosphorylation of 4′-ethynyl 2′,3′-dihydro-3′-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs. Antimicrob Agents Chemother 51(5):1687–1693

    Article  PubMed  CAS  Google Scholar 

  • Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, Shafer RW, Clifford DB, Kallianpur AR, Summar M, Canter JA (2005) Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19(13):1341–1349

    Article  PubMed  Google Scholar 

  • Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dubé M, Grinspoon S, Robbins GK, Motsinger AA, Kallianpur AR, AIDS Clinical Trials Group 384 and A5005s Study Teams (2008) Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy. J Infect Dis 197(6):858–866

    Article  PubMed  CAS  Google Scholar 

  • Imaoka T, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y (2007) Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol 71(2):619–627

    Article  PubMed  CAS  Google Scholar 

  • Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, Brosgart CL, Westland C, Arterbrun S, Deray G, Adefovir Dipivoxil International 437 Study Group, Adefovir Dipivoxil International 438 Study Group (2004) Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies. Kidney Int 66(6):1153–1158

    Article  PubMed  CAS  Google Scholar 

  • Izzedine H, Harris M, Perazella MA (2009) The nephrotoxic effects of hAArT. Nat Rev Nephrol 5(10):563–573

    Article  PubMed  CAS  Google Scholar 

  • Johnson MA, Fridland A (1989) Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol Pharmacol 36(2):291–295

    PubMed  CAS  Google Scholar 

  • Jullig M, Eriksson S (2000) Mitochondrial and submitochondrial localization of human deoxyguanosine kinase. Eur J Biochem 267(17):5466–5472

    Article  PubMed  CAS  Google Scholar 

  • Kakuda TN (2000) Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22(6):685–708

    Article  PubMed  CAS  Google Scholar 

  • Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL (1994) Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO  +  T lymphocytes during HIV-1 infection. Clin Exp Immunol 95(4):436–441

    PubMed  CAS  Google Scholar 

  • Kewn S, Hoggard PG, Sales SD, Johnson MA, Back DJ (2000) The intracellular activation of lamivudine (3TC) and determination of 2′-deoxycytidine-5′-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells. Br J Clin Pharmacol 50(6):597–604

    Article  PubMed  CAS  Google Scholar 

  • Klusa V, Pupure J, Isajevs S, Rumaks J, Gordjushina V, Kratovska A, Taivans I, Svirskis S, Viksna L, Kalvinsh I (2006) Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug. Basic Clin Pharmacol Toxicol 99(4):323–328

    Article  PubMed  CAS  Google Scholar 

  • Kunkel TA, Mosbaugh DW (1989) Exonucleolytic proofreading by a mammalian DNA polymerase. Biochemistry 28(3):988–995

    Article  PubMed  CAS  Google Scholar 

  • Lai Y, Tse CM, Unadkat JD (2004) Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J Biol Chem 279(6):4490–4497

    Article  PubMed  CAS  Google Scholar 

  • Lam W, Chen C, Ruan S, Leung CH, Cheng YC (2005) Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake. Mol Pharmacol 67(2):408–416

    Article  PubMed  CAS  Google Scholar 

  • Lebrecht D, Deveaud C, Beauvoit B, Bonnet J, Kirschner J, Walker UA (2008) Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice. Arthritis Rheum 58(1):318–326

    Article  PubMed  CAS  Google Scholar 

  • Lenzo NP, Garas BA, French MA (1997) Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. AIDS 11(10):1294–1295

    PubMed  CAS  Google Scholar 

  • Leung S, Bendayan R (1999) Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs. Can J Physiol Pharmacol 77(8):625–630

    Article  PubMed  CAS  Google Scholar 

  • Leung GP, Tse CM (2007) The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity. Expert Opin Drug Metab Toxicol 3(5):705–718

    Article  PubMed  CAS  Google Scholar 

  • Lewis W, Dalakas MC (1995) Mitochondrial toxicity of antiviral drugs. Nat Med 1(5):417–422

    Article  PubMed  CAS  Google Scholar 

  • Lewis W, Gonzalez B, Chomyn A, Papoian T (1992) Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 89(4):1354–1360

    Article  PubMed  CAS  Google Scholar 

  • Lewis W, Day BJ, Copeland WC (2003) Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2(10):812–822

    Article  PubMed  CAS  Google Scholar 

  • Lewis W, Haase CP, Miller YK, Ferguson B, Stuart T, Ludaway T, McNaught J, Russ R, Steltzer J, Santoianni R, Long R, Fiermonte G, Palmieri F (2005) Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS. Lab Invest 85(8):972–981

    Article  PubMed  CAS  Google Scholar 

  • Lewis W, Kohler JJ, Hosseini SH, Haase CP, Copeland WC, Bienstock RJ, Ludaway T, McNaught J, Russ R, Stuart T, Santoianni R (2006) Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. AIDS 20(5):675–684

    Article  PubMed  CAS  Google Scholar 

  • Lichtenstein KA, Armon C, Baron A, Moorman AC, Wood KC, Holmberg SD, HIV Outpatient Study Investigators (2005) Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 40(1):148–157

    Article  PubMed  Google Scholar 

  • Lim SE, Copeland WC (2001) Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem 276(26):23616–23623

    Article  PubMed  CAS  Google Scholar 

  • Lim SE, Ponamarev MV, Longley MJ, Copeland WC (2003) Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs. J Mol Biol 329(1):45–57

    Article  PubMed  CAS  Google Scholar 

  • Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, McIntosh K, Colan SD (2000) Absence of cardiac toxicity of zidovudine in infants. Pediatric pulmonary and cardiac complications of vertically transmitted HIV infection study group. N Engl J Med 343(11):759–766

    Article  PubMed  CAS  Google Scholar 

  • Lonergan JT, McComsey GA, Fisher RL, Shalit P, File TM Jr, Ward DJ, Williams VC, Hessenthaler SM, Lindsey L, Hernandez JE, for the ESS40010 (TARHEEL) Study Team (2004) Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir to zidovudine. J Acquir Immune Defic Syndr 36(4):935–942

    Article  PubMed  CAS  Google Scholar 

  • Lund KC, Wallace KB (2004) Direct, DNA pol-gamma-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergetics. Cardiovasc Toxicol 4(3):217–228

    Article  PubMed  CAS  Google Scholar 

  • Lund KC, Wallace KB (2008) Adenosine 3′,5′-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors. Toxicol Appl Pharmacol 226(1):94–106

    Article  PubMed  CAS  Google Scholar 

  • Lynx MD, LaClair DD, McKee EE (2009) Effects of zidovudine and stavudine on mitochondrial DNA of differentiating 3 T3-F442a cells are not associated with imbalanced deoxynucleotide pools. Antimicrob Agents Chemother 53(3):1252–1255

    Article  PubMed  CAS  Google Scholar 

  • Martin JL, Brown CE, Matthews-Davis N, Reardon JE (1994) Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother 38(12):2743–2749

    PubMed  CAS  Google Scholar 

  • Martin AM, Hammond E, Nolan D, Pace C, Den Boer M, Taylor L, Moore H, Martinez OP, Christiansen FT, Mallal S (2003) Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reversetranscriptase inhibitors. Am J Hum Genet 72(3):549–560

    Article  PubMed  CAS  Google Scholar 

  • Mazzucco CE, Hamatake RK, Colonno RJ, Tenney DJ (2008) Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition. Antimicrob Agents Chemother 52(2):598–605

    Article  PubMed  CAS  Google Scholar 

  • McComsey GA, Morrow JD (2003) Lipid oxidative markers are significantly increased in lipoatrophy, but not in sustained asymptomatic hyperlactatemia. J Acquir Immune Defic Syndr 34(1):45–49

    Article  PubMed  CAS  Google Scholar 

  • McComsey G, Tan DJ, Lederman M, Wilson E, Wong LJ (2002) Analysis of mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with of without lipoatrophy. AIDS 16(4):513–518

    Article  PubMed  CAS  Google Scholar 

  • McComsey G, Southwell H, Gripshover B, Salata R, Valdez H (2003) Effect of antioxidants on glucose metabolism and plasma lipids in HIV-infected subjects with lipoatrophy. J Acquir Immune Defic Syndr 33(5):605–607

    Article  PubMed  CAS  Google Scholar 

  • McComsey GA, Ward DJ, Hessenthaler SM, Sension MG, Shalit P, Lonergan JT, Fisher RL, Williams VC, Hernandez JE, Trial to Assess the Regression of Hyperlactatemia and to Evaluate the Regression of Established Lipodystrophy in HIV-1-Positive Subjects (TARHEEL; ESS40010) Study Team (2004) Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study. Clin Infect Dis 38(2):263–270

    Article  PubMed  CAS  Google Scholar 

  • McComsey G, Bai RK, Maa JF, Seekins D, Wong LJ (2005) Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion. J Acquir Immune Defic Syndr 39(2):181–188

    PubMed  CAS  Google Scholar 

  • McKee EE, Bentley AT, Hatch M, Gingerich J, Susan-Resiga D (2004) Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. Cardiovasc Toxicol 4(2):155–167

    Article  PubMed  CAS  Google Scholar 

  • McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE, Hoofnagle JH (1995) Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 333(17):1099–1105

    Article  PubMed  CAS  Google Scholar 

  • Meng Q, Grosovsky AJ, Shi X, Walker VE (2000) Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3′-azido-3′-deoxythymidine. Mutagenesis 15(5):405–410

    Article  PubMed  CAS  Google Scholar 

  • Merta A, Votruba I, Jindrich J, Holý A, Cihlár T, Rosenberg I, Otmar M, Herve TY (1992) Phosphorylation of 9-(2-phosphonomethoxyethyl)adenine and 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine by AMP(dAMP) kinase from L1210 cells. Biochem Pharmacol 44(10):2067–2077

    Article  PubMed  CAS  Google Scholar 

  • Miller KD, Cameron M, Wood LV, Dalakas MC, Kovacs JA (2000) Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med 133(3):192–196

    PubMed  CAS  Google Scholar 

  • Miró O, López S, Rodríguez de la Concepción M, Martínez E, Pedrol E, Garrabou G, Giralt M, Cardellach F, Gatell JM, Vilarroya F, Casademont J (2004) Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. J Acquir Immune Defic Syndr 37(5):1550–1555

    Article  PubMed  Google Scholar 

  • Modica-Napolitano JS (1993) AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem Biophys Res Commun 194(1):170–177

    Article  PubMed  CAS  Google Scholar 

  • Modrzejewski KA, Herman RA (2004) Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor. Ann Pharmacother 38(6):1006–1014

    Article  PubMed  CAS  Google Scholar 

  • Mokrzycki H, Harris C, May H, Laut J, Palmisano J (2000) Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis 30(1):198–200

    Article  PubMed  CAS  Google Scholar 

  • Moore RD, Wong WM, Keruly JC, McArthur JC (2000) Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 14(3):273–278

    Article  PubMed  CAS  Google Scholar 

  • Moreno A, Quereda C, Moreno L, Perez-Elías MJ, Muriel A, Casado JL, Antela A, Dronda F, Navas E, Bárcena R, Moreno S (2004) High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin. Antivir Ther 9(1):133–138

    PubMed  CAS  Google Scholar 

  • Moretti S, Famularo G, Marcellini S, Boschini A, Santini G, Trinchieri V, Lucci L, Alesse E, De Simone C (2002) L-carnitine reduces lymphocyte apoptosis and oxidative stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal 4(3):391–403

    Article  PubMed  CAS  Google Scholar 

  • Morris GW, Iams TA, Slepchenko KG, McKee EE (2009) Origin of pyrimidine deoxyribonucleotide pools in perfused rat heart: implications for 3′-azido-3′-deoxythymidine-dependent cardiotoxicity. Biochem J 422(3):513–520

    Article  PubMed  CAS  Google Scholar 

  • Moyle G (2000) Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. Clin Ther 22(8):911–936

    Article  PubMed  CAS  Google Scholar 

  • Moyle G (2005) Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria. Antivir Ther 10(Suppl 2):M47–M52

    PubMed  CAS  Google Scholar 

  • Moyle GJ, Datta D, Mandalia S, Morlese J, Asboe D, Gazzard BG (2002) Hyperlactatemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS 16(10):1341–1349

    Article  PubMed  Google Scholar 

  • Munch-Petersen B (1984) Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes. Mol Cell Biochem 64(2):173–185

    Article  PubMed  CAS  Google Scholar 

  • Munch-Petersen B, Tyrsted G (1977) Induction of thymidine kinases in phytohaemagglutinin-stimulated human lymphocytes. Biochim Biophys Acta 478(3):364–375

    PubMed  CAS  Google Scholar 

  • Negredo E, Miró O, Rodríguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Morén C, Pérez-Alvarez N, Clotet B, MULTINEKA Study Group (2009) Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). Clin Infect Dis 49(6):892–900

    Article  PubMed  CAS  Google Scholar 

  • Opii WO, Sultana R, Abdul HM, Ansari MA, Nath A, Butterfield DA (2007) Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)–2′,3′-dideoxycytidine (ddC): relevance to HIV-dementia. Exp Neurol 204(1):29–38

    Article  PubMed  CAS  Google Scholar 

  • Panel on Antiretroviral Guidelines for Adults and Adolescents (2008) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services (DHHS), Bethesda, p 139

    Google Scholar 

  • Pan-Zhou XR, Cui L, Zhou XJ, Sommadossi JP, Darley-Usmar VM (2000) Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells. Antimicrob Agents Chemother 44(3):496–503

    Article  PubMed  CAS  Google Scholar 

  • Peltier AC, Russell JW (2006) Advances in understanding drug-induced neuropathies. Drug Saf 29(1):23–30

    Article  PubMed  CAS  Google Scholar 

  • Perno CF, Cooney DA, Gao WY, Hao Z, Johns DG, Foli A, Hartman NR, Caliò R, Broder S, Yarchoan R (1992) Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages. Blood 80(4):995–1003

    PubMed  CAS  Google Scholar 

  • Ronan A, Lipman C, Johnson A, Breen RA (2000) Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals. AIDS 14(5):615–616

    Article  Google Scholar 

  • Rossi L, Serafini S, Schiavano GF, Casabianca A, Vallanti G, Chiarantini L, Magnani M (1999) Metabolism, mitochondrial uptake and toxicity of 2′,3′-dideoxycytidine. Biochem J 344(Pt 3):915–920

    Article  PubMed  CAS  Google Scholar 

  • Rylova SN, Albertioni F, Flygh G, Eriksson S (2005) Activity profiles of deoxynucleoside kinases and 5′-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs. Biochem Pharmacol 69(6):951–960

    Article  PubMed  CAS  Google Scholar 

  • Rylova SN, Mirzaee S, Albertioni F, Eriksson S (2007) Expression of deoxynucleoside kinases and 5′-nucleotidases in mouse tissues: implications for mitochondrial toxicity. Biochem Pharmacol 74(1):169–175

    Article  PubMed  CAS  Google Scholar 

  • Sakamoto S, Iwama T, Tsukada K, Utsunomiya J, Kawasaki T, Okamoto R (1984) Increased activity of thymidine kinase isozyme in human colon tumor. Carcinogenesis 5(2):183–185

    Article  PubMed  CAS  Google Scholar 

  • Sales SD, Hoggard PG, Sunderland D, Khoo S, Hart CA, Back DJ (2001) Zidovudine phosphorylation and mitochondrial toxicity in vitro. Toxicol Appl Pharmacol 177(1):54–58

    Article  PubMed  CAS  Google Scholar 

  • Scadden DT, Pickus O, Hammer SM, Stretcher B, Bresnahan J, Gere J, McGrath J, Agosti JM (1996) Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 12(12):1151–1159

    Article  PubMed  CAS  Google Scholar 

  • Schramm C, Wanitschke R, Galle PR (1999) Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis. Eur J Anaesthesiol 16(10):733–735

    PubMed  CAS  Google Scholar 

  • Semino-Mora MC, Leon-Monzon ME, Dalakas MC (1994) Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves AZTinduced changes and prevents further destruction. Lab Invest 71(5):773–781

    PubMed  CAS  Google Scholar 

  • Setzer B, Lebrecht D, Walker UA (2008) Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine. Am J Pathol 172(3):681–690

    Article  PubMed  CAS  Google Scholar 

  • Shaer AJ, Rastegar A (2000) Lactic acidosis in the setting of antiretroviral therapy for the acquired immunodeficiency syndrome. A case report and review of the literature. Am J Nephrol 20(4):332–338

    Article  PubMed  CAS  Google Scholar 

  • Shikuma CM, Hu N, Milne C, Yost F, Waslien C, Shimizu S, Shiramizu B (2001) Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS 15(14):1801–1809

    Article  PubMed  CAS  Google Scholar 

  • Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, Pinti M, Cossarizza A, Shikuma C (2003) Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving HAART during pregnancy. J Acquir Immune Defic Syndr 32(4):370–374

    Article  PubMed  CAS  Google Scholar 

  • Skuta G, Fischer GM, Janaky T, Kele Z, Szabo P, Tozser J, Sumegi B (1999) Molecular mechanism of the short-term cardiotoxicity caused by 2′,3′-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions. Biochem Pharmacol 58(12):1915–1925

    Article  PubMed  CAS  Google Scholar 

  • Smyth K, Affandi JS, McArthur JC, Bowtell-Harris C, Mijch AM, Watson K, Costello K, Woolley IJ, Price P, Wesselingh SL, Cherry CL (2007) Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993–2006. HIV Med 8(6):367–373

    Article  PubMed  CAS  Google Scholar 

  • Song S, Pursell ZF, Copeland WC, Longley MJ, Kunkel TA, Mathews CK (2005) DNA precursor asymmetries in mammalian tissue mitochondria and possible contribution to mutagenesis through reduced replication fidelity. Proc Natl Acad Sci USA 102(14):4990–4995

    Article  PubMed  CAS  Google Scholar 

  • Sussman HE, Olivero OA, Meng Q, Pietras SM, Poirier MC, O’Neill JP, Finette BA, Bauer MJ, Walker VE (1999) Genotoxicity of 3′-azido-3′-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT. Mutat Res 429(2):249–259

    PubMed  CAS  Google Scholar 

  • Szabados E, Fischer GM, Toth K, Csete B, Nemeti B, Trombitas K, Habon T, Endrei D, Sumegi B (1999) Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic Biol Med 26(3–4):309–317

    Article  PubMed  CAS  Google Scholar 

  • Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, D’agati VD (2001) Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol 32(7):734–740

    Article  PubMed  CAS  Google Scholar 

  • Tesco G, Latorraca S, Piersanti P, Piacentini S, Amaducci L, Sorbi S (1992) Protection from oxygen radical damage in human diploid fibroblasts by acetyl-L-carnitine. Dementia 3:58–60

    Google Scholar 

  • Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281(5381):1312–1316

    Article  PubMed  CAS  Google Scholar 

  • Tsai CH, Doong SL, Johns DG, Driscoll JS, Cheng YC (1994) Effect of anti-HIV 2′-beta-fluoro-2′,3′-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production. Biochem Pharmacol 48(7):1477–1481

    Article  PubMed  CAS  Google Scholar 

  • Tuon FF, Guastini CM, Boulos MI (2008) Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis. Braz J Infect Dis 12(4):263

    Article  PubMed  Google Scholar 

  • Turriziani O, Butera O, Gianotti N, Parisi SG, Mazzi R, Girardi E, Iaiani G, Antonelli L, Lazzarin A, Antonelli G (2005) Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients. AIDS 19(5):473–479

    Article  PubMed  CAS  Google Scholar 

  • Uwai Y, Ida H, Tsuji Y, Katsura T, Inui K (2007) Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Pharm Res 24(4):811–815

    Article  PubMed  CAS  Google Scholar 

  • Valenti D, Barile M, Quagliariello E, Passarella S (1999) Inhibition of nucleoside diphosphate kinase in rat liver mitochondria by added 3′-azido-3′-deoxythymidine. FEBS Lett 444(2–3):291–295

    Article  PubMed  CAS  Google Scholar 

  • Valenti D, Atlante A, Barile M, Passarella S (2002) Inhibition of phosphate transport in rat heart mitochondria by 3′-azido-3′-deoxythymidine due to stimulation of superoxide anion mitochondrial production. Biochem Pharmacol 64(2):201–206

    Article  PubMed  CAS  Google Scholar 

  • Velsor LW, Kovacevic M, Goldstein M, Leitner HM, Lewis W, Day BJ (2004) Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine. Toxicol Appl Pharmacol 199(1):10–19

    Article  PubMed  CAS  Google Scholar 

  • Venhoff N, Setzer B, Melkaoui K, Walker UA (2007) Mitochondrial toxicity of tenofovir, emtricitabine, and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Antivir Ther 12(7):1075–1085

    PubMed  CAS  Google Scholar 

  • Vrouenraets SM, Treskes M, Regez RM, Troost N, Smulders YM, Weigel HM, Frissen PH, Brinkman K (2002) Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment. Antivir Ther 7(4):239–244

    PubMed  CAS  Google Scholar 

  • Wada S, Tsuda M, Sekine T, Cha SH, Kimura M, Kanai Y, Endou H (2000) Rat multispecifi c organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther 294(3):844–849

    PubMed  CAS  Google Scholar 

  • Walker UA, Venhoff N (2005) Uridine in the prevention and treatment of NRTI related mitochondrial toxicity. Antivir Ther 10(supp 2):M117–M123

    PubMed  CAS  Google Scholar 

  • Walker UA, Setzer B, Venhoff N (2002) Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS 16(16):2165–2173

    Article  PubMed  CAS  Google Scholar 

  • Walker UA, Bäuerle J, Laguno M, Murillas J, Mauss S, Schmutz G, Setzer B, Miquel R, Gatell JM, Mallolas J (2003) Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Hepatology 39(2):311–317

    Article  CAS  Google Scholar 

  • Wallace DC (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256(5057):628–632

    Article  PubMed  CAS  Google Scholar 

  • Wang L, Eriksson S (2003) Mitochondrial deoxyguanosine kinase mutations and mitochondrial DNA depletion syndrome. FEBS Lett 554(3):319–322

    Article  PubMed  CAS  Google Scholar 

  • Ward JL, Sherali A, Mo ZP, Tse CM (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-defi cient PK15 cells. Ent2 exhibits a low affi nity for guanosine and cytidine but a high affi nity for inosine. J Biol Chem 275(12):8375–8381

    Article  PubMed  CAS  Google Scholar 

  • Wiesner RJ, Ruegg JC, Morano I (1992) Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues. Biochem Biophys Res Commun 183(2):553–559

    Article  PubMed  CAS  Google Scholar 

  • Wu Y, Li N, Zhang T, Wu H, Huang C, Chen D (2009) Mitochondrial DNA base excision repair and mitochondrial DNA mutation in human hepatic HuH-7 cells exposed to stavudine. Mutat Res 664(1–2):28–38

    PubMed  CAS  Google Scholar 

  • Yamanaka G, Wilson T, Innaimo S, Bisacchi GS, Egli P, Rinehart JK, Zahler R, Colonno RJ (1999) Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus. Antimicrob Agents Chemother 43(1):190–193

    PubMed  CAS  Google Scholar 

  • Yamanaka H, Gatanaga H, Kosalaraksa P, Matsuoka-Aizawa S, Takahashi T, Kimura S, Oka S (2007) Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment. J Infect Dis 195(10):1419–1425

    Article  PubMed  CAS  Google Scholar 

  • Zeviani M, Di Donato S (2004) Mitochondrial disorders. Brain 127(Pt10):2153–2172

    Article  PubMed  Google Scholar 

  • Zhang XS, Jin R, Zhang SB, Tao ML (2008) Clinical features of adverse reactions associated with telbivudine. World J Gastroenterol 14(22):3549–3553

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China

    George P. H. Leung

Authors
  1. George P. H. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George P. H. Leung .

Editor information

Editors and Affiliations

  1. School of Medicine, Institute of Biochemistry and Clinical B, Catholic University, Largo A. Gemelli 8, Rome, 00168, Italy

    Roberto Scatena

  2. School of Medicine, Institute of Biochemistry and Clinical B, Catholic University, Largo A. Gemelli 8, Rome, 00168, Italy

    Patrizia Bottoni

  3. School of Medicine, Institute of Biochemistry and Clinical B, Catholic University, Largo A. Gemelli 8, Rome, 00168, Italy

    Bruno Giardina

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Leung, G.P.H. (2012). Iatrogenic Mitochondriopathies: A Recent Lesson from Nucleoside/Nucleotide Reverse Transcriptase Inhibitors. In: Scatena, R., Bottoni, P., Giardina, B. (eds) Advances in Mitochondrial Medicine. Advances in Experimental Medicine and Biology, vol 942. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2869-1_16

Download citation

Publish with us

Policies and ethics

Search

Navigation